RVNC 241220 3.50C (RVNC241220C3500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

RVNC241220C3500

Watchlist

0.05
0.000.00%

15min DelayClose Dec 12 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Shareholder Alert: Ademi LLP Investigates Whether Revance Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Businesswire11:30 ET
Revance Therapeutics Board Recommends Stockholders Tender Shares to Crown Laboratories
MT NewswiresDec 12 10:55 ET
Express News | Crown Laboratories: Tender Offer Is Scheduled to Expire at One Minute After 11:59 P.m., Eastern Time on January 13, 2025
ReutersDec 12 08:10 ET
Revance Therapeutics Board of Directors Recommend Stockholders Tender Their Shrs >RVNC
Dow JonesDec 12 08:02 ET
Press Release: Crown Laboratories Commences Friendly Tender Offer for All Outstanding Common Shares of Revance Therapeutics at $3.10 per Share
Dow JonesDec 12 08:00 ET
Revance Therapeutics Is Maintained at Neutral by Mizuho
Dow JonesDec 10 08:19 ET · Ratings

Comments

Dan1993

Dec 10 01:35

$Revance Therapeutics (RVNC.US)$ The offer price $3.1 is 20% less than Friday's close price. Is it offer or clearance sell? Why does the CEO of RVNC accepted such bad hair-cut offer from previous $6.66. Mark J. Foley should be fired immediately without any compensation. Let's vote

Jaguar8

Dec 9 07:38

NEWS

$Revance Therapeutics (RVNC.US)$
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced an amended merger agreement where Crown will acquire all outstanding Revance shares for $3.10 per share in cash through a tender offer. The amendment comes after several developments, including Revance's settlement with Teoxane regarding distribution agreements and revised brand guidelines, which are expect...

Dan1993

Dec 6 13:41

$Revance Therapeutics (RVNC.US)$The two parties might already reached an agreement yesterday, but finalizing the documentation and making announcement it on Monday morning.

Dan1993

Dec 5 17:02

There are more than 11 extensions for the deal. It is a positive sign as both parties want to make a deal. DaxinbotulinumtoxinA received approval from China is a bigger deal. It helps deal price >$6

$Revance Therapeutics (RVNC.US)$

Dan1993

Nov 26 08:14

$Revance Therapeutics (RVNC.US)$ It is a bullish sign as the extension only has 4 days. It has a deal